It’s fair to say that burns treatment specialist PolyNovo was a rising star in 2020.
The biotech appeared resilient to the headwinds of COVID-19, managing to grow sales in the second half of that financial year, despite access to hospitals being restricted in some markets.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
